Cerulean Announces Proposed Public Offering of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/19/2026
- Tech selloff weighs down Wall Street as bond yields climb
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Tech selloff weighs down Wall Street as bond yields climb
- Francisco Partners to acquire Weave Communications for $650M
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Goldman Sachs to acquire real estate company LCN for up to $410M
- BofA raises hyperscaler AI capex outlook to $3.6tn through 2028
Cerulean Pharma (CERU) Prices 5.84M Common Offering at $6/Share
April 7, 2015 6:15 AM EDTCerulean Pharma (NASDAQ: CERU) announced the pricing of an underwritten public offering of 5,840,000 shares of its common stock at a public offering price of $6.00 per share, before underwriting discounts. All of the shares in the offering are being offered by Cerulean. In addition,... More
Cerulean Pharma (CERU) to Offer $50M in Common Stock
March 30, 2015 4:23 PM EDTCerulean Pharma (NASDAQ: CERU) commenced an underwritten public offering of approximately $50 million of shares of its common stock. The number of shares to be offered and the price per share for the proposed offering have not yet been determined. All of... More
